| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Eicosapentaenoic Acid | Diabetes Type 2 | 5 | PM | 38589346 | 📋 | The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial |
| Eicosapentaenoic Acid | Diabetes Type 2 | 4 | PM | 35709423 | 📋 | Potential Mechanisms by Which Hydroxyeicosapentaenoic Acids Regulate Glucose Homeostasis In Obesity |
| Eicosapentaenoic Acid | Diabetes Type 2 | 1 | PM | 32723580 | 📋 | The effects of aspirin and N-3 fatty acids on telomerase activity in adults with diabetes mellitus |
| Eicosapentaenoic Acid | Diabetes Type 2 | 2 | PM | 29034644 | 📋 | The Effect of Eicosapentaenoic Acid on the Serum Levels and Enzymatic Activity of Paraoxonase 1 in the Patients With Type 2 Diabetes Mellitus |
| Eicosapentaenoic Acid | Diabetes Type 2 | 3 | PM | 19403992 | 📋 | Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes |
| Eicosapentaenoic Acid | Hyperglycemia | 1 | PM | 34507608 | 📋 | Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice |
| Eicosapentaenoic Acid | Hypertriglyceridemia | 3 | PM | 38382916 | 📋 | Pleiotropic beneficial cardiometabolic actions of a high-purity eicosapentaenoic acid product in high cardiovascular risk individuals |
| Eicosapentaenoic Acid | Hypertriglyceridemia | 2 | PM | 33750272 | 📋 | Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Lower Extremity Arterial Disease |
| Eicosapentaenoic Acid | Hypertriglyceridemia | 1 | PM | 32861211 | 📋 | Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acid |
| Eicosapentaenoic Acid | Insulin Resistance | 7 | PM | 34575127 | 📋 | Effect of Eicosapentaenoic Acid Supplementation on Murine Preadipocytes 3T3-L1 Cells Activated with Lipopolysaccharide and/or Tumor Necrosis Factor-α |
| Eicosapentaenoic Acid | Insulin Resistance | 6 | PM | 34507608 | 📋 | Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice |
| Eicosapentaenoic Acid | Insulin Resistance | 5 | PM | 33631425 | 📋 | Oleic Acid and Eicosapentaenoic Acid Reverse Palmitic Acid-induced Insulin Resistance in Human HepG2 Cells via the Reactive Oxygen Species / JUN Pathway |
| Eicosapentaenoic Acid | Insulin Resistance | 4 | PM | 33476356 | 📋 | Anti-obesity effects of DHA and EPA in high fat-induced insulin resistant mice |
| Eicosapentaenoic Acid | Insulin Resistance | 1 | PM | 32298529 | 📋 | Eicosapentaenoic and Docosahexaenoic Acids Differentially Alter Gut Microbiome and Reverse High-Fat Diet-Induced Insulin Resistance |
| Eicosapentaenoic Acid | Insulin Resistance | 2 | PM | 20861209 | 📋 | Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation |
| Eicosapentaenoic Acid | Insulin Resistance | 3 | PM | 19277604 | 📋 | n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet |
| Eicosapentaenoic Acid | Metabolic Disorders | 4 | PM | 33561210 | 📋 | The Inhibition of Metabolic Inflammation by EPA Is Associated with Enhanced Mitochondrial Fusion and Insulin Signaling in Human Primary Myotubes |
| Eicosapentaenoic Acid | Metabolic Disorders | 3 | PM | 33543364 | 📋 | Transgenerational supplementation with eicosapentaenoic acid reduced the metabolic consequences on the whole body and skeletal muscle in mice receiving an obesogenic diet |
| Eicosapentaenoic Acid | Metabolic Disorders | 2 | PM | 33008057 | 📋 | Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects |
| Eicosapentaenoic Acid | Metabolic Disorders | 1 | PM | 32992508 | 📋 | Protective Effects of Eicosapentaenoic Acid Plus Hydroxytyrosol Supplementation Against White Adipose Tissue Abnormalities in Mice Fed a High-Fat Diet |
| Eicosapentaenoic Acid | Metabolic Syndrome | 3 | PM | 34229258 | 📋 | Effects of dietary eicosapentaenoic acid and docosahexaenoic acid supplementation on metabolic syndrome: A systematic review and meta-analysis of data from 33 randomized controlled trials |
| Eicosapentaenoic Acid | Metabolic Syndrome | 2 | PM | 33652751 | 📋 | Fish Oil Enriched in EPA, but Not in DHA, Reverses the Metabolic Syndrome and Adipocyte Dysfunction Induced by a High-Fat Diet |
| Eicosapentaenoic Acid | Metabolic Syndrome | 1 | PM | 32792029 | 📋 | The impact of EPA and DHA on ceramide lipotoxicity in metabolic syndrome |
| Eicosapentaenoic Acid | Obesity | 11 | PM | 37240054 | 📋 | Temperature-Dependent Effects of Eicosapentaenoic Acid (EPA) on Browning of Subcutaneous Adipose Tissue in UCP1 Knockout Male Mice |
| Eicosapentaenoic Acid | Obesity | 10 | PM | 35709423 | 📋 | Potential Mechanisms by Which Hydroxyeicosapentaenoic Acids Regulate Glucose Homeostasis In Obesity |
| Eicosapentaenoic Acid | Obesity | 9 | PM | 34619367 | 📋 | Beneficial effects of eicosapentaenoic acid on the metabolic profile of obese female mice entails upregulation of HEPEs and increased abundance of enteric Akkermansia Muciniphila |
| Eicosapentaenoic Acid | Obesity | 8 | PM | 33652751 | 📋 | Fish Oil Enriched in EPA, but Not in DHA, Reverses the Metabolic Syndrome and Adipocyte Dysfunction Induced by a High-Fat Diet |
| Eicosapentaenoic Acid | Obesity | 7 | PM | 33476356 | 📋 | Anti-obesity effects of DHA and EPA in high fat-induced insulin resistant mice |
| Eicosapentaenoic Acid | Obesity | 2 | PM | 32906847 | 📋 | Eicosapentaenoic Acid Regulates Inflammatory Pathways through Modulation of Transcripts and miRNA in Adipose Tissue of Obese Mice |
| Eicosapentaenoic Acid | Obesity | 6 | PM | 27598198 | 📋 | Eicosapentaenoic and Docosahexaenoic Acid-Enriched High Fat Diet Delays Skeletal Muscle Degradation in Mice |
| Eicosapentaenoic Acid | Obesity | 1 | PM | 27507611 | 📋 | Effects of Dietary Supplementation With EPA and/or α-Lipoic Acid on Adipose Tissue Transcriptomic Profile of Healthy Overweight/Obese Women Following a Hypocaloric Diet |
| Eicosapentaenoic Acid | Obesity | 5 | PM | 20861209 | 📋 | Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation |
| Eicosapentaenoic Acid | Obesity | 4 | PM | 18850226 | 📋 | Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes |
| Eicosapentaenoic Acid | Obesity | 3 | PM | 17569885 | 📋 | Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects |
| Eicosapentaenoic Acid | Overweight | 1 | PM | 27507611 | 📋 | Effects of Dietary Supplementation With EPA and/or α-Lipoic Acid on Adipose Tissue Transcriptomic Profile of Healthy Overweight/Obese Women Following a Hypocaloric Diet |
| Eicosapentaenoic Acid | Overweight | 2 | PM | 18850226 | 📋 | Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes |
